Blog - INTERNET MÉDICA

Apolipoproteína B & Prevenção Cardiovascular (Apolipoprotein B in Cardiovascular Risk Assessment: FTTKA)

Por Paulo Leite 31/08/2023

■ Série Five Things to know About/Canadian Medical Journal Association

– A medição da apolipoproteína (apo) B é uma alternativa recomendada ao colesterol da lipoproteína de baixa densidade (LDL-C)

– Apolipoproteína B prevê com precisão o risco cardiovascular

– A Sociedade Cardiovascular Canadense fornece uma diretriz para o uso do marcador na prática clínica

– A apolipoproteína B tem vantagens práticas sobre outras medidas

– Alguns pacientes com níveis aparentemente satisfatórios de colesterol de lipoproteína de baixa densidade apresentam níveis elevados de apolipoproteína

■ Apolipoprotein B in cardiovascular risk assessment – Five Things to Know About

M Alhamd, A D Sniderman, R A Hegele

CMAJ 2023, vol 195 (33): E1124

https://www.cmaj.ca/content/195/33/E1124

■ 2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular

G J Pearson, G Thanassoulis, T J Anderson et al

Can J Cardiol 2021, vol 37: 1129-1150

https://www.onlinecjc.ca/article/S0828-282X(21)00165-3/fulltext

■ Acesso gratuito

■ Um dos Blog de Medicina mais acessado em todo o mundo. Mais de 900 temas médicos já disponíveis online

■ Use o mecanismo de busca – PESQUISAR na home page.

■ Acesse ARQUIVO e encontre os temas incluídos no Blog a cada mês, desde maio 2017

■ Blog Internet Médica – www.internetmedica.com.br

■ Médico Responsável: Dr Paulo Fernando Leite

CRMMG: 7026

Belo Horizonte/MG/Brasil

Email: pfleite1873@gmail.com

Abril 2023

Câncer Colorretal: Diretrizes Médicas 2023 (Colon Cancer: Guideline)

Por Paulo Leite 31/08/2023

■ Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metástases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE

Ajith K Siriwardena, Alejandro Serrablo, Åsmund Avdem Fretland, ET AL

Br J Surg. 2023 Sep; 110(9): 1161–1170

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416695/

■ Transplante hepático por metástases hepáticas irresecables de câncer colorrectal: revisión de la literatura

D García et al

Rev méd Chile 2022, vol 150 (5): p.656-663

https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872022000500656&lng=es&nrm=iso

■ Colon cancer screening methods: 2023 update

M Jayasinghe, O Prathiraja, D Caldera et al

Cureus 2023, vol 15 (4): e37509

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182334/

■ Association of the 2018 World Cancer Research Fund/American Institute of Cancer Research (WCRF/AICR) cancer prevention recommendations with stages of colorectal carcinogenesis

Ane Sørlie Kværner, Astrid Riseth Andersen, Hege Berg Henriksen et al

Cancer Med. 2023 Jul; 12(13): 14806–14819

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358192/

■ Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment, and follow-up of patients with metastatic colorectal cancer

Yoshino, A. Cervantes, H. Bando, et al

ESMO Open. 2023 Jun; 8(3): 101558

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220270/

■ Joint Asian Pacific Association of Gastroenterology (APAGE) – Asian Pacific Society of Digestive Endoscopy (APSDE) clinical practice guidelines on the use of non-invasive biomarkers for diagnosis of colorectal neoplasia

Francis K L Chan, Martin C S Wong, Andrew T Chan, James E East, et al

Gut. 2023 Jul; 72(7): 1240–1254

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314015/

■ Systematic review of shared decidion-making in guidelines about colorectal cancer screening

Marta Maes‐Carballo, Manuel García‐García, Yolanda Gómez‐Fandiño, et al

Eur J Cancer Care (Engl) 2022 Nov; 31(6): e13738

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786598/

■ Translation of IDEA trial results into clinical practice: analysis of the implementation of a new guideline for colon cancer

Karlijn L. van Rooijen, Jeroen W. G. Derksen, Helena M. Verkooijen et al

Int J Cancer. 2022 Oct 15; 151(8): 1270–1279

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545923/

■ Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the British Society of Gastroenterology (BSG)

Kevin J Monahan, Michael M Davies, Muti Abulafi, et al

Gut. 2022 Oct; 71(10): 1939–1962

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484376/